A detailed history of Russell Investments Group, Ltd. transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 86 shares of HOWL stock, worth $141. This represents 0.0% of its overall portfolio holdings.

Number of Shares
86
Holding current value
$141
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.71 - $2.95 $147 - $253
86 New
86 $0
Q4 2021

Jan 21, 2022

SELL
$11.48 - $17.65 $1.45 Million - $2.22 Million
-125,873 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$13.89 - $20.31 $1.75 Million - $2.56 Million
125,873 New
125,873 $2.16 Million

Others Institutions Holding HOWL

About Werewolf Therapeutics, Inc.


  • Ticker HOWL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,529,400
  • Market Cap $48.4M
  • Description
  • Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...
More about HOWL
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.